XOMA insider transaction filings
XOMA Royalty Corp — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-16. Screen XOMA transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-16 | 4 | BVF PARTNERS L P/IL — 10% owner BIOTECHNOLOGY VALUE FUND L P — 10% owner BVF I GP LLC — 10% owner BIOTECHNOLOGY VALUE FUND II LP — 10% owner BVF II GP LLC — 10% owner Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC — 10% owner BVF INC/IL — 10% owner LAMPERT MARK N — 10% owner | Code (U): 3,635,758 · Code (U): 2,773,545 · Code (U): 412,000 · Code (U): 772,000 | EDGAR |
| 2026-07-14 | 4 | Montano Maricel Perea — Chief Legal Officer | Other (J): 42,306 · Other (J): 65 · Disposition to issuer (D): 37,074 (derivative) @ $0 · Disposition to issuer (D): 11,316 (derivative) @ $0 | EDGAR |
| 2026-07-14 | 4 | Sitko Bradley — Chief Investment Officer | Other (J): 83,765 · Disposition to issuer (D): 313 · Disposition to issuer (D): 7,045 · Other (J): 1,287 · Other (J): 75 · Other (J): 75 · +7 more | EDGAR |
| 2026-07-14 | 4 | Trigilio Jeffrey — Chief Financial Officer | Other (J): 103,906 · Disposition to issuer (D): 126,924 (derivative) @ $0 · Disposition to issuer (D): 26,000 (derivative) @ $0 | EDGAR |
| 2026-07-14 | 4 | Hernday Natasha — Director | Other (J): 9,304 · Disposition to issuer (D): 4,000 · Disposition to issuer (D): 13,251 (derivative) @ $0 · Disposition to issuer (D): 5,101 (derivative) @ $0 · Disposition to issuer (D): 8,996 (derivative) @ $0 · Disposition to issuer (D): 10,967 (derivative) @ $0 · +1 more | EDGAR |
| 2026-07-14 | 4 | Kosacz Barbara — Director | Other (J): 6,269 · Disposition to issuer (D): 19,979 (derivative) @ $0 · Disposition to issuer (D): 8,167 (derivative) @ $0 · Disposition to issuer (D): 6,152 (derivative) @ $0 · Disposition to issuer (D): 5,101 (derivative) @ $0 · Disposition to issuer (D): 8,996 (derivative) @ $0 · +2 more | EDGAR |
| 2026-07-14 | 4 | Hughes Owen — Chief Executive Officer, Director | Other (J): 191,264 · Other (J): 752 · Disposition to issuer (D): 102,000 · Disposition to issuer (D): 100,000 (derivative) @ $0 · Disposition to issuer (D): 75,000 (derivative) @ $0 · Disposition to issuer (D): 116,245 (derivative) @ $0 · +1 more | EDGAR |
| 2026-07-14 | 4 | PERRY MATTHEW D — Director | Other (J): 24,138 · Disposition to issuer (D): 15,222 (derivative) @ $0 · Disposition to issuer (D): 5,052 (derivative) @ $0 · Disposition to issuer (D): 8,167 (derivative) @ $0 · Disposition to issuer (D): 6,152 (derivative) @ $0 · Disposition to issuer (D): 5,101 (derivative) @ $0 · +2 more | EDGAR |
| 2026-07-14 | 4 | Franklin Heather L — Director | Other (J): 6,269 · Disposition to issuer (D): 17,282 (derivative) @ $0 · Disposition to issuer (D): 8,996 (derivative) @ $0 · Disposition to issuer (D): 10,967 (derivative) @ $0 · Disposition to issuer (D): 9,763 (derivative) @ $0 | EDGAR |
| 2026-07-14 | 4 | LIMBER JOSEPH M — Director | Other (J): 9,532 · Disposition to issuer (D): 10,000 · Disposition to issuer (D): 20,000 · Disposition to issuer (D): 8,000 (derivative) @ $0 · Disposition to issuer (D): 2,366 (derivative) @ $0 · Disposition to issuer (D): 5,052 (derivative) @ $0 · +7 more | EDGAR |
| 2026-07-14 | 4 | WYSZOMIERSKI JACK L — Director | Other (J): 21,828 · Disposition to issuer (D): 8,000 (derivative) @ $0 · Disposition to issuer (D): 2,366 (derivative) @ $0 · Disposition to issuer (D): 5,052 (derivative) @ $0 · Disposition to issuer (D): 8,167 (derivative) @ $0 · Disposition to issuer (D): 6,152 (derivative) @ $0 · +3 more | EDGAR |
| 2026-05-26 | 4 | Hernday Natasha — Director | Grant/award (A): 3,586 @ $0 | EDGAR |
| 2026-05-26 | 4 | Kosacz Barbara — Director | Grant/award (A): 3,586 @ $0 | EDGAR |
| 2026-05-26 | 4 | PERRY MATTHEW D — Director | Grant/award (A): 3,586 @ $0 | EDGAR |
| 2026-05-26 | 4 | Franklin Heather L — Director | Grant/award (A): 3,586 @ $0 | EDGAR |
| 2026-05-26 | 4 | LIMBER JOSEPH M — Director | Grant/award (A): 3,586 @ $0 | EDGAR |
| 2026-05-26 | 4 | WYSZOMIERSKI JACK L — Director | Grant/award (A): 3,586 @ $0 | EDGAR |
| 2026-05-18 | 4 | BVF PARTNERS L P/IL — 10% owner BIOTECHNOLOGY VALUE FUND L P — 10% owner BVF I GP LLC — 10% owner BIOTECHNOLOGY VALUE FUND II LP — 10% owner BVF II GP LLC — 10% owner Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC — 10% owner BVF INC/IL — 10% owner LAMPERT MARK N — 10% owner | Conversion (C): 2,313,000 @ $4.03 · Conversion (C): 1,506,000 @ $4.03 · Conversion (C): 412,000 @ $4.03 · Conversion (C): 772,000 @ $4.03 · Conversion (C): 2,313 (derivative) @ $0 · Conversion (C): 1,506 (derivative) @ $0 · +2 more | EDGAR |
| 2026-04-22 | 4 | Montano Maricel Perea — Chief Legal Officer | Option exercise (M): 3,370 @ $0 · Option exercise (M): 3,370 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | Sitko Bradley — Chief Investment Officer | Option exercise (M): 3,737 @ $0 · Option exercise (M): 3,737 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | Trigilio Jeffrey — Chief Financial Officer | Option exercise (M): 11,538 @ $0 · Option exercise (M): 11,538 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | Hughes Owen — Chief Executive Officer, Director | Option exercise (M): 10,568 @ $0 · Option exercise (M): 10,568 (derivative) @ $0 | EDGAR |
| 2026-04-15 | 4 | Trigilio Jeffrey — Chief Financial Officer | Option exercise (M): 4,000 @ $0 · Tax withholding (F): 1,632 @ $36.76 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2026-03-31 | 4 | LIMBER JOSEPH M — Director | Option exercise (M): 3,026 @ $11.20 · Option exercise (M): 3,026 (derivative) @ $0 | EDGAR |
| 2026-03-26 | 4 | WYSZOMIERSKI JACK L — Director | Option exercise (M): 3,026 @ $11.20 · Option exercise (M): 3,026 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Hughes Owen — Chief Executive Officer, Director | Grant/award (A): 82,428 @ $0 · Grant/award (A): 126,813 (derivative) @ $0 | EDGAR |
| 2026-03-13 | 4 | Montano Maricel Perea — Chief Legal Officer | Grant/award (A): 26,289 @ $0 · Grant/award (A): 40,444 (derivative) @ $0 | EDGAR |
| 2026-03-13 | 4 | Sitko Bradley — Chief Investment Officer | Grant/award (A): 30,000 @ $0 · Grant/award (A): 29,402 @ $0 · Grant/award (A): 44,849 (derivative) @ $0 | EDGAR |
| 2026-03-13 | 4 | Trigilio Jeffrey — Chief Financial Officer | Grant/award (A): 90,000 @ $0 · Grant/award (A): 138,462 (derivative) @ $0 | EDGAR |
| 2026-01-14 | 4 | Trigilio Jeffrey — Chief Financial Officer | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-12-08 | 4 | Hughes Owen — Chief Executive Officer, Director | Purchase (P): 100,000 @ $25.05 | EDGAR |
| 2025-09-23 | 4 | Montano Maricel Perea — Chief Legal Officer | Option exercise (M): 3,033 @ $0 · Option exercise (M): 3,033 (derivative) @ $0 | EDGAR |
| 2025-09-23 | 4 | Sitko Bradley — Chief Investment Officer | Option exercise (M): 6,712 @ $0 · Option exercise (M): 6,712 (derivative) @ $0 | EDGAR |
| 2025-09-23 | 4 | BURNS THOMAS M. — SVP, Finance & CFO | Option exercise (M): 11,846 @ $0 · Sale (S): 4,300 @ $35.98 · Sale (S): 15 @ $36.93 · Sale (S): 15 @ $36.81 · Option exercise (M): 11,846 (derivative) @ $0 | EDGAR |
| 2025-09-23 | 4 | Hughes Owen — Chief Executive Officer, Director | Option exercise (M): 35,567 @ $0 · Option exercise (M): 35,567 (derivative) @ $0 | EDGAR |
| 2025-09-12 | 4 | Montano Maricel Perea — Chief Legal Officer | Option exercise (M): 9,101 @ $0 · Option exercise (M): 9,101 (derivative) @ $0 | EDGAR |
| 2025-08-14 | 4 | Montano Maricel Perea — Chief Legal Officer | Grant/award (A): 23,450 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Sitko Bradley — Chief Investment Officer | Purchase (P): 2,000 @ $25.39 | EDGAR |
| 2025-05-23 | 4 | Hernday Natasha — Director | Grant/award (A): 5,971 @ $0 | EDGAR |
| 2025-05-23 | 4 | Kosacz Barbara — Director | Grant/award (A): 5,971 @ $0 | EDGAR |
| 2025-05-23 | 4 | Kosacz Barbara — Director | Grant/award (A): 5,971 @ $0 | EDGAR |
| 2025-05-23 | 4 | PERRY MATTHEW D — Director | Grant/award (A): 5,971 @ $0 | EDGAR |
| 2025-05-23 | 4 | Franklin Heather L — Director | Grant/award (A): 5,971 @ $0 | EDGAR |
| 2025-05-23 | 4 | LIMBER JOSEPH M — Director | Grant/award (A): 9,936 (derivative) @ $0 | EDGAR |
| 2025-05-23 | 4 | WYSZOMIERSKI JACK L — Director | Grant/award (A): 5,971 @ $0 | EDGAR |
| 2025-05-21 | 4 | BURNS THOMAS M. — SVP, Finance & CFO | Option exercise (M): 17,773 @ $0 · Sale (S): 10,482 @ $25.38 · Option exercise (M): 17,773 (derivative) @ $0 | EDGAR |
| 2025-05-21 | 4 | Hughes Owen — Chief Executive Officer, Director | Option exercise (M): 53,359 @ $0 · Sale (S): 25,637 @ $25.38 · Option exercise (M): 53,359 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | BVF PARTNERS L P/IL — 10% owner BIOTECHNOLOGY VALUE FUND L P — 10% owner BVF I GP LLC — 10% owner BIOTECHNOLOGY VALUE FUND II LP — 10% owner BVF II GP LLC — 10% owner Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC — 10% owner BVF INC/IL — 10% owner LAMPERT MARK N — 10% owner | Sale (S): 127,407 @ $27.10 · Sale (S): 265,316 @ $27.10 | EDGAR |
| 2025-04-09 | 4 | Sitko Bradley — Chief Investment Officer | Purchase (P): 2,000 @ $24.70 | EDGAR |
| 2025-04-07 | 4 | LIMBER JOSEPH M — Director | Purchase (P): 16,524 @ $25.22 · Purchase (P): 1,411 @ $25.44 · Purchase (P): 3,476 @ $25.25 · Purchase (P): 3,346 @ $25.56 · Purchase (P): 5,243 @ $25.60 | EDGAR |
Recent 8-K events — XOMA Royalty Corp
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-14 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-12 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-22 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-18 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-27 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-27 | 8-K/A | 2.01 — Completion of Acquisition or Disposition of Assets 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-18 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-02 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-09 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-02 | 8-K/A | 2.01 — Completion of Acquisition or Disposition of Assets 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=XOMA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →